VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,031,000 | +4200.0% | 456,087 | +10110.1% | 0.04% | +2150.0% |
| Q1 2016 | $117,000 | -66.2% | 4,467 | +130.0% | 0.00% | -71.4% |
| Q3 2015 | $346,000 | -93.6% | 1,942 | -92.0% | 0.01% | -90.0% |
| Q2 2015 | $5,425,000 | +13.7% | 24,422 | +1.6% | 0.07% | +14.8% |
| Q1 2015 | $4,772,000 | +233.2% | 24,026 | +140.1% | 0.06% | +258.8% |
| Q4 2014 | $1,432,000 | +123.1% | 10,007 | +96.4% | 0.02% | +142.9% |
| Q2 2014 | $642,000 | -81.1% | 5,094 | -80.2% | 0.01% | -87.0% |
| Q1 2014 | $3,397,000 | +78.4% | 25,771 | +59.0% | 0.05% | +86.2% |
| Q4 2013 | $1,904,000 | +192.9% | 16,212 | +160.4% | 0.03% | +190.0% |
| Q3 2013 | $650,000 | – | 6,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |